- Home
- APAM vs RNA Comparison
APAM vs RNA Comparison
Compare APAM & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APAM
- RNA
- Stock Information
- Founded
- APAM 1994
- RNA 2012
- Country
- APAM United States
- RNA United States
- Employees
- APAM N/A
- RNA N/A
- Industry
- APAM Investment Managers
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- APAM Finance
- RNA Health Care
- Exchange
- APAM Nasdaq
- RNA Nasdaq
- Market Cap
- APAM 2.7B
- RNA 3.7B
- IPO Year
- APAM 2013
- RNA 2020
- Fundamental
- Price
- APAM $39.62
- RNA $26.74
- Analyst Decision
- APAM Hold
- RNA Strong Buy
- Analyst Count
- APAM 4
- RNA 12
- Target Price
- APAM $44.38
- RNA $68.25
- AVG Volume (30 Days)
- APAM 646.1K
- RNA 1.4M
- Earning Date
- APAM 04-22-2025
- RNA 05-08-2025
- Dividend Yield
- APAM 8.83%
- RNA N/A
- EPS Growth
- APAM 14.69
- RNA N/A
- EPS
- APAM 3.66
- RNA N/A
- Revenue
- APAM $1,111,802,000.00
- RNA $10,897,000.00
- Revenue This Year
- APAM $7.39
- RNA N/A
- Revenue Next Year
- APAM $7.04
- RNA $134.34
- P/E Ratio
- APAM $10.77
- RNA N/A
- Revenue Growth
- APAM 14.02
- RNA 13.98
- 52 Week Low
- APAM $37.89
- RNA $21.56
- 52 Week High
- APAM $49.54
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- APAM 41.85
- RNA 36.75
- Support Level
- APAM $38.45
- RNA $30.12
- Resistance Level
- APAM $41.87
- RNA $33.13
- Average True Range (ATR)
- APAM 0.94
- RNA 2.19
- MACD
- APAM -0.01
- RNA -0.34
- Stochastic Oscillator
- APAM 36.30
- RNA 1.93
About APAM Artisan Partners Asset Management Inc.
Artisan Partners Asset Management Inc is a global investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are primarily offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.